CA2181390C - Formulations a base de phospholipides - Google Patents

Formulations a base de phospholipides Download PDF

Info

Publication number
CA2181390C
CA2181390C CA002181390A CA2181390A CA2181390C CA 2181390 C CA2181390 C CA 2181390C CA 002181390 A CA002181390 A CA 002181390A CA 2181390 A CA2181390 A CA 2181390A CA 2181390 C CA2181390 C CA 2181390C
Authority
CA
Canada
Prior art keywords
phosphatidylcholin
cholesterol
triolin
cellulose
dipalmitoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002181390A
Other languages
English (en)
Other versions
CA2181390A1 (fr
Inventor
Pankaj Modi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generex Pharmaceuticals Inc
Original Assignee
Generex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generex Pharmaceuticals Inc filed Critical Generex Pharmaceuticals Inc
Publication of CA2181390A1 publication Critical patent/CA2181390A1/fr
Application granted granted Critical
Publication of CA2181390C publication Critical patent/CA2181390C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CA002181390A 1995-07-18 1996-07-17 Formulations a base de phospholipides Expired - Fee Related CA2181390C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US147395P 1995-07-18 1995-07-18
US60/001,473 1995-07-18

Publications (2)

Publication Number Publication Date
CA2181390A1 CA2181390A1 (fr) 1997-01-19
CA2181390C true CA2181390C (fr) 2001-04-24

Family

ID=21696188

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002181390A Expired - Fee Related CA2181390C (fr) 1995-07-18 1996-07-17 Formulations a base de phospholipides

Country Status (1)

Country Link
CA (1) CA2181390C (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132765A (en) * 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
BR0317876A (pt) * 2002-12-31 2005-12-06 Nicholas V Perricone Composições de liberação de droga tópica estáveis
CA2660310C (fr) 2006-03-30 2015-04-21 The Research Foundation Of State University Of New York Compositions de complexes proteine-lipide moins immunogeniques et a circulation prolongee
US7875288B2 (en) 2006-03-30 2011-01-25 The Research Foundation Of State University Of New York Method for treating blood coagulation disorders
JP2014508166A (ja) 2011-03-17 2014-04-03 トランスダーマル バイオテクノロジ インコーポレーテッド 局所的一酸化窒素システム及びその使用方法
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
CN111278441A (zh) * 2017-10-11 2020-06-12 巴斯特生物技术 用于治疗纤维化的组合物和方法
CN114010801B (zh) * 2021-11-16 2023-09-26 上海理工大学 一种l-抗坏血酸棕榈酸酯修饰的小分子肽脂质体及其制备与应用

Also Published As

Publication number Publication date
CA2181390A1 (fr) 1997-01-19

Similar Documents

Publication Publication Date Title
CA2181390C (fr) Formulations a base de phospholipides
US6214375B1 (en) Phospholipid formulations
US4844904A (en) Liposome composition
EP0243446B1 (fr) Vesicules a base d'alpha-tocopherol
EP0572049B1 (fr) Liposomes
US4877561A (en) Method of producing liposome
JP2958774B2 (ja) アンホテリシンｂリポソームの改良調整法
US4853228A (en) Method of manufacturing unilamellar lipid vesicles
US6132763A (en) Liposomes
WO1990014074A1 (fr) Formulations liposomiques ameliorees de nucleotides et d'analogues de nucleotides
CA2266622C (fr) Systeme hyaluronique d'administration de medicaments
JPH08505882A (ja) リポソーム調製法及び物質のカプセル化方法
JPS60231609A (ja) リポソ−ム製剤
YUDA et al. Prolongation of liposome circulation time by various derivatives of polyethyleneglycols
EP0208764A1 (fr) Procede de conservation de liposomes
ITMI20090350A1 (it) Glicerosomi e loro impiego in preparazioni farmaceutiche e cosmetiche per uso topico
US5525232A (en) Method for entrapment of cationic species in lemellar vesicles
US5173219A (en) Uniform spherical multilamellar liposomes of defined and adjustable size distribution
US20090324709A1 (en) Liposomal formulations
WO2016108634A2 (fr) Nanostructure multi-lamellaire de type hybride de facteur de croissance épidermique et liposome et procédé de fabrication associé
US6656497B2 (en) Liposomal vector for active-principle
Cevc Drug-carrier and stability properties of the long-lived lipid vesicles. Cryptosomes, in vitro and in vivo
Wasankar et al. Liposome as a drug delivery system-a review
JPS6352010B2 (fr)
JPH06345663A (ja) バンコマイシン含有リポソーム製剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed